ABT-737 Induces Bim Expression via JNK Signaling Pathway and Its Effect on the Radiation Sensitivity of HeLa Cells-Reference-Cited by-同舟云学术

ABT-737 Induces Bim Expression via JNK Signaling Pathway and Its Effect on the Radiation Sensitivity of HeLa Cells

Published:2012-12-20 Issue:12 Volume:7 Page:e52483
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wang Huan,Yang Yue-Bo,Shen Hui-Min,Gu Jian,Li Tian,Li Xiao-Mao

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy[J];MH Kang;Clin Cancer Res,2009

2. Inhibition of p38 MAPK enhances ABT-737-induced cell death in melanoma cell lines: novel regulation of PUMA[J];AM Keuling;Pigment Cell Melanoma Res,2010

3. Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells[J];B Will;Blood,2010

4. Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress[J];G Dasmahapatra;Cancer Biol Ther,2009

5. MEK inhibition enhances ABT-737-induced leukemia cell apoptosisi via prevention of ERK-activated MCL-1/BIM complex [J];M Konopleva;Theor Appl Genet,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma;ACS Omega;2023-07-17

2. Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer;Frontiers in Oncology;2022-03-25

3. Bcl-xL DNAzymes promote radiosensitivity and chemosensitivity in colorectal cancer cells via enhancing apoptosis;BMC Pharmacology and Toxicology;2022-02-05

4. HPV16 E6E7 up-regulates KIF2A expression by activating JNK/c-Jun signal, is beneficial to migration and invasion of cervical cancer cells;Open Medicine;2022-01-01

5. Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling;Pancreatology;2021-06